RSS

CYDY CytoDyn Inc

Last Post: 10/12/26
Followers: 439
Posts Today: 0
Views Today: 52378

CYDY Stock Quote & Tools

$0.2000 ▲ +0.0000 (+0.00%) As of Oct 12, 3:52 PM EDT
Last0.2000
$ Chg0.0000
Open0.1982
High0.2072
Beta1.4964
Year High0.397
Market Cap293.90M
P/B Ratio-2.68
EPS-0.03
Avg Vol (30d)1.60M
Volume1.17M
% Chg+0.00%
Prev Close0.2000
Low0.1970
VWAP0.19940
Year Low0.183
Total Shares1.47B
Shares Out1.47B
Float1.36B
ExchangeOTCQB
Healthcare Biotechnology & Life Sciences

CYDY Stock Message Board Discussion

  1. JLang

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

New Insights from Dupixent® and Itepekimab at ERS 2024

Updated Category News Views 281

Scientific Innovation in Respiratory Diseases Recent findings presented at the European Respiratory Society (ERS) Congress highlight remarkable progress in treating chronic obstructive pulmonary disease (COPD), asthma, and chronic rhinosinusitis with nasal polyps (CRSwNP). With a total of 20 abstracts, including four oral presentations, researchers have unveiled new...

Continue Reading
Marketeam.ai Secures Top Honors for AI Marketing Innovation

Updated Category News Views 154

Marketeam.ai Shines at the AI Breakthrough Awards Marketeam.ai has recently received the prestigious 'Proactive AI Assistance Solution of the Year' award at the annual AI Breakthrough Awards, a celebration of innovation in artificial intelligence. This recognition highlights the pioneering role Marketeam.ai plays in the field of automated marketing solutions. Innovative...

Continue Reading
LightPath Technologies Secures Major Order for Infrared Cameras

Updated Category News Views 90

Significant Purchase Order Announcement LightPath Technologies, Inc. (NASDAQ: LPTH) has recently announced a substantial $9.6 million purchase order for cooled infrared cameras from a valued defense customer. This order emphasizes the company’s strong partnership with its client and highlights the increasing demand for advanced imaging systems in defense and security...

Continue Reading
Earnings Season Insights: Major Bank Reports Highlight Trends

Updated Category News Views 249

Earnings Season Insights: What the Reports Reveal The recent earnings reports from major banks have painted a mixed yet insightful picture of the current economic landscape. These reports indicate a strong start to the Q2 earnings season, driven primarily by trading and investment banking activities. Despite the impressive results, CEOs have expressed a cautious stance...

Continue Reading
Alumis and ACELYRIN Merger: A Transformative Step Forward

Updated Category News Views 197

Alumis Finalizes Strategic Merger with ACELYRIN In a significant development, Alumis Inc. (Nasdaq: ALMS), a biopharma company specializing in innovative therapies for immune-mediated diseases, has officially completed its merger with ACELYRIN, Inc. This merger marks a pivotal moment for Alumis as it strengthens its position in the biopharmaceutical industry. Details of...

Continue Reading